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Abstract
The purpose of this study was to determine whether primary care providers
(PCPs) in Mississippi are following the selected Centers for Disease Control and
Prevention (CDC) guidelines published in March 2016 for prescribing opioids for
chronic, non-cancer pain. The study also sought to determine if the selected providers
prescribed naloxone for opioid overdose reversal. Drug overdoses have increased
exponentially in the last 3 decades in the United States (Doyon, Aks, & Schaeffer, 2014)
— leading to opioid overdose becoming the most frequent cause of accidental death.
Opioid overdose death rates are so high the CDC declared it a problem o f “epidemic”
status in 2012 (Canada, DiRocco, & Day, 2014).
Mississippi ranks as one o f the highest prescribing states for opioid analgesics.
For the purpose of this research, focus was placed on specific aspects o f the CDC
guidelines as follows: (a) consider nonpharmacological treatment or treat with nonopioids

first, (b) avoid prescribing opioids and benzodiazepines concurrently, and (c) check a
urine drug screen prior to opioid initiation and yearly thereafter (CDC, 2016). The CDC
now recommends prescribing naloxone, an opioid antagonist, to patients at risk for opioid
overdose. Naloxone has demonstrated effectiveness in reducing opioid overdose
mortality.
A nonexperimental, quantitative, descriptive, retrospective review of charts was
performed in 6 primary care clinics in Mississippi staffed by physicians and family nurse
practitioners. A convenience sampling o f 600 charts for retrospective chart review was
conducted. Inclusion criteria were age 18 years or older, medically treated long-term
with opioids (> 2 prescriptions written >21 days apart) for chronic non-cancer pain, and
prescribed by a PCP.
The findings suggested that PCPs in Mississippi are not eonsistently following
CDC guidelines for opioid prescribing. It should also be noted that, o f the 600 charts
reviewed, none o f the patients were prescribed naloxone for reversal of a potential opioid
overdose. Research demonstrated a need for increased awareness and education among
PCPs regarding CDC guidelines for prescribing opioids.
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CHAPTER I
Dimensions of the Problem
Drug overdoses have increased exponentially in the last three decades in the
United States (Doyon, Aks, & Schaeffer, 2014). More alarmingly, the leading cause of
accidental death in the United States (U.S.) is overdose, specifically opioid overdose.
Because opioid overdose death rates are so high, the Centers for Disease Control (CDC)
declared this drug a problem o f “epidemic” status in 2012 (Canada, DiRocco, & Day,
2014). In 2013, over 43,000 deaths were reportedly due to drug overdose in the U.S.
Fifty-six percent were opioid-related deaths; o f these, 37% were related to analgesic
opioid prescription drugs (Wheeler, Jones, Gilbert, & Davidson, 2015). Prescription
opioids account for the greatest negative effects associated with prescription misuse.
Mississippi ranks as one o f the highest prescribing states for opioid analgesics
where most pain medications prescribed are written by primary care providers and
dentists. As o f July 2016, hydrocodone is the most prescribed controlled substance in
Mississippi, followed by alprazolam and oxycodone. These alarming statistics spotlight
a major area o f concern in our state for primary care providers (Mississippi State
Department of Health, 2012)
Opioids can produce effects of pleasure where patients may intentionally abuse
to seek self-gratification. This addiction is a serious problem that affects the health and
social welfare of our society. Risk factors for overdose include receipt of more than 50
mg morphine equivalents, concurrent benzodiazepine use, or substance use disorder as
reported by the American Medical Association, the Medical Board o f California, and
the Centers for Disease Control (CDC) (Behar, Rowe, Santos, Murphy, & Coffin,

13

2016). Due to growing concern over opioid misuse and overdose, recent guidelines
have been published by the CDC to assist providers in safely prescribing these drugs.
For the purpose of this research, focus was placed on specific aspects o f these
guidelines as follows;
1. Consider nonpharmacologic treatment or treat with nonopioids first.
2. Avoid prescribing opioids and benzodiazepines concurrently.
3. Check a urine drug screen prior to opioid initiation and yearly thereafter
(CDC, 2016).
Recently, recommendations have been made to prescribe naloxone, an opioid
antagonist, to patients at risk for opioid overdose. Reductions in opioid overdose
mortality have been associated with the increased distribution of naloxone. As of
August 2016, all states in the U.S. allow physicians and practitioners to prescribe
naloxone to laypersons. Despite having the ability to prescribe naloxone, limited data
exist suggesting that primary care providers are seeking recommendations to preseribe
naloxone (Behar et al., 2016). Naloxone is a life-saving treatment that has increasingly
been prescribed by some providers as an opioid reversal agent. Prescription naloxone
has reversed more than 10,000 overdose cases between 1996 and 2010 according to the
CDC (2016). However, rural communities have underutilization to many addiction
treatment facilities which commonly offer naloxone. A study by Behar et al. (2016)
found that when naloxone is prescribed by primary care providers the distribution is
higher than with community distribution alone. Behar et al.’s (2016) statistical
findings regarding naloxone were alarming and are as follows: 87% of patients reported
they were prescribed opioids for pain, 53% reported taking opioids in a manner other
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than as prescribed, 37% reported seeking medical treatment for overdose, 53% reported
witnessing an overdose, and 27% reported being administered naloxone. Furthermore,
90% o f patients had never received naloxone, 60% had never heard of it before the
intervention, and 82% filled the prescription. These findings demonstrate that naloxone
is drastically underutilized as a lifesaving reversal agent. (Behar et al., 2016)
Factors such as patient safety and addiction rates are primary concerns of
prescribers. These concerns are justifiable as the misuse of prescription opioids is a
major problem in the U.S. Incorporating screening and opioid education may be the
first step by primary care providers in the prevention of opioid drug abuse. Providers
may need to initiate a screening tool that highlights risk of misuse, especially for those
prescribed opioids for chronic pain. Additionally, opioid education should be a key
element of chronic non-cancer pain treatment modalities. The opioid overdose
epidemic, whether intentional or accidental, continues to rise.
For the purpose o f this research, focus was placed on the following: (a)
adherence in Mississippi to select CDC guidelines for opioids; (b) prescribing
frequency o f naloxone by primary care providers; and (e) opioid education among
chronic, non-cancer pain patients. Focus on these key areas may highlight areas with
needed improvement in regard to Mississippi’s opioid prescribing practices.
Purpose of the Research Project
The purpose o f this study was to determine whether primary care providers in
Mississippi are following the selected CDC guidelines, as outlined through questions
posed by the current researchers for prescribing opioids and whether those providers
prescribed naloxone for opioid overdose reversal. The selected questions follow the
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treatment progression recommended by the CDC in regard to chronic, non-cancer pain
treatment which is outlined as follows: nonpharmacologic therapy, nonopioid therapy,
and obtaining a urine drug screen prior to initiating opioid therapy and then annually. It
is also recommended to avoid concurrent benzodiazepine and opioid prescriptions.
Furthermore, the current researchers determined whether naloxone was being prescribed
and whether education regarding opioid risks and opioid reversal was provided.
Significance of the Research Project
Overdose deaths due to opioids were recognized as an epidemic in 2012 (Doyon
et al., 2012). Drug overdose-related deaths have surpassed deaths related to motor
vehicle crashes. Now, deaths due to opioid overdose have exceeded the combined total
deaths due to heroin and cocaine overdose (Center for Mississippi Health Policy, 2013).
Healthcare providers lacked a general consensus on treatment o f chronic, non-cancer
pain prior to the release o f the CDC’s latest guidelines. This research project was
designed to determine if prescribers in a defined region are adhering to the guidelines
set forth by the CDC.
Future researchers can utilize results from this research to assess the urgency for
further dissemination of education among practitioners regarding opioid prescribing
practices in Mississippi. The results of this research identified the need for all
healthcare providers, including nurse practitioners, to follow the selected CDC
guidelines and provide patient education regarding opioid use. The lack of patient
education regarding the side effects o f opioids leads to misuse— oftentimes resulting in
lethal overdose. In addition to patient education, provider education regarding
appropriate chronic, non-cancer pain management aides healthcare providers in
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increasing compliance and safety. This research also identified whether or not
providers are prescribing naloxone for opioid overdose. Prescribing naloxone could be
a significant component to caring for patients suffering from opioid addiction.
Research regarding prescription naloxone is significant because naloxone has been
shown to decrease deaths related to opioid overdose.
The information obtained through this research demonstrates implications to all
healthcare providers, including nurse practitioners. Primary care providers need to be
prepared to provide proper treatment to these patients by being aware of the CDC
prescribing guidelines so that patients are not inappropriately prescribed opioids. Also,
nurse practitioners need to be aware o f naloxone for opioid overdose so they can make
an informed decision about prescribing or not prescribing naloxone.
Another component o f prescribing opioids which holds significance
predominantly to nurse practitioners in the primary care setting is education about
opioid use. Nurse practitioners need to realize the impact they have on their patients
when prescribing opioids. Each clinic visit is an opportunity for practitioners to educate
patients about opioid use and misuse. Patients need to understand that improper use can
be lethal. When nurse practitioners enforce the selected CDC prescribing guidelines,
consider naloxone for opioid overdose and provide patient education. Enforcement of
these guidelines could decrease the likelihood o f negative outcomes due to opioid
overdose.
Conceptual Framework
The theory proposed by Nola J. Pender, PhD, RN, FAAN, is entitled the Flealth
Promotion Model (HPM). The HPM was the theoretical foundation for this body o f
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work. This model reflects a holistic view o f nursing in which providers see patients as
people who are responsible for their health and wellness. One significant goal of this
research was to expound the relevance o f the HPM for opioid prescribing practices in
Mississippi.
To better understand the HPM and the application of the model to practice,
Pender defined many major concepts and definitions. These concepts and definitions
have expanded over the years; therefore, they are even more relevant to the promotion
o f healthy lifestyles. The HPM consists o f the following major concepts: individual
characteristics and experiences, behavior-specific cognitions and affect, and behavioral
outcome (Alligood, 2014). Providers use each of these concepts to predict how a
patient might respond during certain behavioral situations. The following discussion of
a research article review provides further explanation o f the concepts and definitions of
Pender’s theory applied in practice.
In the research, Nola Pender highlighted patient behavioral responses when
counseled on the importance o f physical activity. According to Eden, Orleans, Mulrow,
Pender, and Teutsch (2002), the findings revealed that most patients struggle to
maintain exercise goals. Eden et al. (2002) related the struggles to factors, such as
differences in activity levels at the baseline and decreased provider intervention.
Utilizing Pender’s model in this study allowed the researchers to analyze the motive for
physical inactivity.
Eden et al. (2002) first examined the individual characteristics and experiences
of the population under study. These characteristics and experiences included sedentary
lifestyles and minimal healthy habits. The behavior speeific cognitions and affect
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during the first part of the study revealed many barriers to action due to low selfefficacy (Eden et ah, 2002). There were no specific interpersonal or situational
influences listed. Due to the increased level o f barriers to action (i.e., overweight, out
o f shape, and sedentary), the patients’ perceived benefits of action did not result in
health-promoting behaviors. However, after input and counsel from providers, the
patients’ behavior specific cognitions and affect changed. The outcome was healthpromoting behaviors (Eden et al., 2002). The application of the HPM in this research
mirrors how the current researchers applied the HPM to chronic pain patients.
As previously mentioned, the purpose this research was to explore opioidprescribing practices in Mississippi and the use of naloxone for opioid overdose
reversal. The HPM was used in this study to explore practitioners’ tendencies to
encourage health-promoting lifestyles to chronic pain patients. The HPM also was used
as a guideline to assess positive or negative behavioral outeomes o f opioid prescription
to chronic pain patients.
The guidelines for opioid-prescribing set forth by the CDC can also be
incorporated into the HPM. These recommendations served as a beneficial guide to this
research project relating to chronic opioid use. Nola Pender’s HPM predicts patients’
tendencies on how everyone will participate in the behaviors that improve health.
Pender’s model has contributed to health promotion and has provided practitioners the
framework to motivate patients to attain a state o f well-being. The CDC guidelines also
assist practitioners and other medical professionals with the appropriate measures
necessary for monitoring the safety of individuals with chronic opioid use. Data

19
pertinent to this research can be hypothesized with the use o f such guidelines; therefore,
information can be examined for the continuum of research on this topic.
Research Questions
Health promotion is important in motivating patients with chronic pain to attain
a healthier lifestyle by avoiding misuse of opioids. The purpose of this study was to
explore whether primary eare providers were following guidelines for prescribing
opioids, prescribing naloxone as an opioid reversal agent, and providing sufficient
education to patients prescribed opioids. The following research questions addressed
each topic:
1. Are primary care providers in Mississippi compliant with the following
selection o f the CDC’s latest guidelines for prescribing opioids for chronic
pain?
a. Nonpharmacologic therapy or nonopioid pharmacologic therapy first.
b. Avoid concurrent prescribing of opioids and benzodiazepines.
c.

Check urine drug screen prior to opioid initiation and then annually.
2. Are primary care providers in Mississippi prescribing naloxone for opioid
overdose reversal?
3. Do primary care providers provide education to patients regarding opioid
overdose?
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Definitions of Terms
For the purpose o f this study, the following terms were defined with both
theoretical and operational definitions. The theoretical definitions are concrete and
broad. The operational definitions are abstract and define the utilization of terminology
as it pertains to this research project.
Primary care providers (PCP)
Theoretical: The healthcare provider (i.e., the nurse practitioner, physician’s
assistant, or physician) to whom a patient first goes to address a problem with his or her
health (Venes, 2013).
Operational: A healthcare provider who sees people that have common medical
problems. This person may be physician, physician assistant, or a nurse practitioner.
Centers for Disease Control and Prevention (CDC) guidelines
Theoretical: A set o f current and relevant guidelines published by a division o f
the U.S. Public Health Service headquartered in Atlanta, Georgia, that investigates and
controls various diseases, especially those that have epidemic potential. The agency is
also responsible for national programs to improve laboratory conditions and encourage
health and safety (Venes, 2013).
Operational: A set of guidelines published by the CDC which offers
recommendations for prescribing practices regarding the management of chronic, non
cancer pain. Specifically, the CDC recommends that prescribers follow the treatment
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progression as follows: nonpharmacologic therapy, nonopioid therapy, and obtain drug
screen initially and then annually before prescribing opioids.
Opioids
Theoretical: Any synthetic narcotic not derived from opium (Venes, 2013).
Operational: A synthetic drug designed to mimic the effects o f opium or
opiates; a narcotic prescribed by primary care providers to patients in this study.
Chronic pain
Theoretical: Long-lasting discomfort, with episodic exacerbations. Pain that
lasts more than 3 months. Pain that lasts more than a month longer than the usual or
expected course of illness or injury (Venes, 2013).
Operational: Pain lasting longer than 12 weeks or longer than normal tissue
healing.
Non pharmacologic therapy
Theoretical: Any therapy prescribed or recommended to improve health or
wellness— not related to the use o f drugs (Laurence, 2010).
Operational: Any therapy used to treat pain, excluding pharmaceutical drugs;
including, but not limited to, cognitive behavioral therapy, physical therapy, exercise
therapy, weight loss, biopsychosocial therapy, multimodal pain therapy, and
interventional therapy.
Nonopioid pharmacologic therapy
Theoretical: The use of any medicinal treatment to reduce pain, with the
exception of drugs falling within the chemical classification o f opioids.
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Operational: A drug therapy used to treat pain, excluding the opioid class of
drugs; including, but not limited to, acetaminophen, nonsteroidal anti-inflammatory
drugs, anticonvulsants, and antidepressants.
Concurrent prescribing (opioids and benzodiazepines)
Theoretical: Happening at the same time; simultaneous writing, or
administering, of medications such as opioids and benzodiazepines.
Operational: Writing or administering opioids with benzodiazepines which is
contraindicated by the latest CDC guidelines.
Benzodiazepines
Theoretical: Any group of chemically similar psychotropic drugs with potent
hypnotic and sedative action; used predominantly as antianxiety and sleep-inducing
drugs (Venes, 2013).
Operational: A class o f drugs that can be harmful if taken in excessive amounts.
Urine drug screen
Theoretical: A test used to detect illegal and some prescription drugs in the
urine including opioids and benzodiazepines.
Operational: Testing performed prior to prescribing of opioids to establish
current social and medical habits and repeated periodically throughout care to confirm
proper administration and avoid concurrent use with other drugs prescribed or illegal.
Naloxone
Theoretical: A drug that is antagonistic to the actions o f narcotics and opiates,
such as morphine, methadone, and opium. It is helpful in reversing the respiratory
depression caused by an overdose of narcotics (Venes, 2013).
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Operational: A drug prescribed by primary care providers in an outpatient
setting to reverse the effects of opioid overdose.
Overdose
Theoretical: An excessive and potentially toxic amount of a medication given in
error or taken intentionally (Venes, 2013).
Operational: An excessive or toxic amount o f opioid ingestion requiring
administration of the reversal agent—naloxone.
Education
Theoretical: Health information and instruction to help patients leam about
specific or general medical topics, such as preventive services, the adoption of healthy
lifestyles, the correct use of medications, or the care of diseases or injuries at home
(Venes, 2013).
Operational: Information given to a patient regarding proper usage of opioids
and the risks associated with opioids, such as central nervous system depression that
could lead to respiratory depression or arrest. Education should also include risk o f
dependence as well as avoidance o f alcohol and other sedatives.
Patient(s)
Theoretical: One who is sick with, or being treated for, an illness or injury
(Venes, 2013).
Operational: One who is 18 years of age or older and is currently being treated
for ehronic pain with the use of opioid pain medication.
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Assumptions
Assumptions in this study included the following:
1. Adherence to CDC guidelines by primary care providers in regard to opioidprescribing practices will reduce the risk o f opioid related overdose and
opioid misuse.
2. Naloxone prescription may prevent a fatal overdose secondary to opioid
overdose but may increase risky behavior in patients presenting with chronic
pain.
3. Patients presenting to the clinic with complaints of acute pain were being
screened for chronic pain.
4. Primary care providers in Mississippi are following the latest CDC guidelines
when prescribing opioids.
The current researchers assumed that the data required to perform this research
would be available upon the review of the charts and data would be organized and
comprehensible. It was assumed that data would be collected in a legal and ethical
manner. Finally, it was assumed that the data collected would be correctly interpreted
by the researchers.
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CHAPTER II
Literature Review
The purpose o f this study was to determine whether primary care providers were
following GDC guidelines for prescribing opioids and whether these providers were
prescribing naloxone for opioid overdose reversal. Drug overdoses have increased over
the last three decades in the U.S., and Mississippi ranks as one of the highest states for
prescribing opioids. The most frequent opioids prescribed, according to the Mississippi
State Department o f Health in 2012, are hydrocodone and oxycodone. Prescription
opioid abuse leads to unintended overdoses and ultimately can result in death. These
overdoses are related to patients’ behavioral experiences regarding opioid use.
To expand knowledge o f opioid overdoses and providers’ prescribing habits,
this research group reviewed numerous research articles. This chapter will present the
conceptual framework and related literature through various research articles. The
framework for this study and the literature review were used as evidence promoting the
need for stricter compliance o f CDC-prescribing guidelines and improved education for
patients regarding opioid overdose. The literature review also highlighted the
importance o f prescription naloxone for opioid overdoses.
Conceptual Framework
In determining a conceptual framework for this research, the student researchers
reviewed several studies which utilized Pender’s HPM as the theoretical basis. One
study which employed Pender’s HPM was conducted by Conway, McClune, and Nosel
(2007). The study focused on a significant problem in the U.S. regarding children’s
safety and the agriculture industry. Agriculture surpasses all others by measure of
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dangerous workplaces, with an accidental work-related death rate six times greater than
all other industries combined (Conway et al., 2007). In 1999, the National Agricultural
Statistics Service (NASS) reported there were over 2 million farms nationwide. On
these farms, 1.5 million children lived and/or worked. Reportedly, over 100,000
injuries occur annually in children while on farms. O f these, 100 children die each year.
Conway et al. (2007) conducted this pilot study to examine farm safety
education for families and children provided by healthcare professionals. The
researchers used Pender’s model to depict how primary care providers (PCPs) promote
healthy behaviors in their practice regarding farm safety education. Furthermore, the
study was threefold in purpose: (a) quantify the number o f farm accidents through PCPs
healthcare records, (b) determine barriers to safety equipment or protocol, and (c)
determine the rate at which PCPs provide education regarding farm safety. The
conceptual framework for the study was based on Pender’s HPM. The researchers
discussed one of Pender’s major assumptions that individuals are constantly
transforming their surroundings, while at the same time their surroundings are
constantly transforming the individual. Conway et al. (2007) stated that, “The
individual variable o f perceived benefits o f action, personal barriers of action, perceived
self-efficacy, activity-related effects, situational influences, and interpersonal influences
can be modified to increase health-promoting behaviors” (p. 45).
The method utilized was a survey that focused on farm safety issues confronted
by PCPs. Included in the survey were demographics, documented farm injuries, and
PCPs’ knowledge o f farm safety educational materials. A panel of experts reviewed the
content for validity. A convenienee sample of 110 PCPs was used from 5 separate
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northwestern Pennsylvania counties. The surveys were sent out via mail to be returned
anonymously with prepaid return envelopes; follow-up reminders were sent at 2 weeks
to increase response rates. There was a low return of 22 surveys.
The returned surveys included PCPs as the participants. These PCPs were
medical, osteopathic, and chiropractic physicians; physician’s assistants; and nurse
practitioners. Injuries reported included lacerations, animal injuries, muscle strains,
machinery/equipment injury, and one fatality. One child was mauled by an animal and
required surgery. Forty-five percent of PCP’s reported that their initial assessments
included questioning new patients if children lived or worked on a farm. Eighteen
percent (18%) of PCPs reported performing specific education on farm injury
prevention. Only 5% had related handouts available for distribution; however, 73%
voiced interest in attaining farm injury prevention materials.
The results of Conway et al.’s (2007) study found that additional education is
recommended to promote safer farm environments for children. A limitation o f the
study would be generalization. A continuation of the pilot study would be required for
validation using a larger population. Potentially, a continuation study could provide
data to ensure health-promoting resources to decrease farm-related injuries and death.
Agazio and Buckley (2010) conducted a study to explore women’s health
promotion behaviors in the U.S. military. In this study, the researchers used a
descriptive correlational design. Their conceptual framework was based on Pender’s
HPM, specifically two categories o f factors: personal factors and behavior-specific
cognitions. The purpose o f the study was to differentiate between causative factors for
health-promoting behaviors. Personal factors were defined as demographic
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characteristics, perceived health status, and definition of health (Agazio & Buckley,
2010) while behavior-specific cognitions were defined as perceived self-efficacy and
interpersonal influences (Agazio & Buckley, 2010).
The research questions focused on these personal factors and behavior-specific
cognitions and their correlation to demographics, interpretations o f health, self-worth,
and resources. Another research objective was to decipher the differences among
healthy behaviors in differing groups o f military women. Agazio and Buckley (2010)
believed that with more women involved in the military, there was a growing burden of
balancing work and family responsibilities. Agazio and Buckley predicted that this, in
turn, affected health-promoting behaviors. The population sample was comprised of
491 military women and included active duty, reservists, childbearing, and non
childbearing individuals. The participants were recruited from 2 military hospitals and
enrolled voluntarily via phone or email. Up to 150 participants were included in each
group. If a participant volunteered, a study packet was sent with a stamped envelope to
the participant. Included in the packet was a study instrument with instructions to
complete and return in the stamped envelope. The study instrument included 2 of
Pender’s resources, the Perceived Health Status (Pender, Walker, Frank-Stromborg, &
Sechrist, 1990) and the Health-Promoting Lifestyle Profile II (HPLP-II) (Pender et al.,
1990); other instruments were included in the packet (Agazio & Buckley, 2010).
The instruments attained quantitative measurement of each o f Pender’s HPM
variables and utilized several Likert-rating scales. Descriptive statistics were used and
determined statistical significance o f the data. Pearson correlation coefficients were
also used to interpret the research findings. The research concluded that 59% of
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participants were on active duty and 51.2% had children. The average age of
participants was 37.2 years. Surprisingly, the most significant finding was the
comparison between active duty women with children (ADWWC) and all other
categories. ADWWC scored significantly higher for all health-promoting behaviors
which was not the anticipated outcome based on previous research by Agazio and
Buckley (2010). The researchers explained the findings, assuming ADWWC high
scores were due to time management skills, improved organization, and increased
awareness and commitment to personal wellness. The researchers suggested these
attributes may have been acquired during motherhood due to role modeling and
conscious efforts towards building healthy behaviors in children. Other findings were
that all groups scored the highest in spiritual growth. Accordingly, all groups scored the
lowest on ability to manage stress.
Agazio and Buckley (2010) concluded that, though the study validated Pender’s
model o f behavior-specific cognitions (perceived self-efficacy and interpersonal
resources), none o f the personal characteristics (age, marital status, ethnicity, health
conception scale, and personal health status) were determined to be significant
indicators o f health promotion amongst the groups. Limitations to the study could have
consisted o f higher proportion o f Caucasians, sample age median o f 37 years,
recruitment site for participants, and possible lack of causative factors not identified in
the study. The variance could have been explained in more detail had the researchers
identified situational influences, barriers to health, and benefits o f health promotion
from Pender’s most recent HPM. Another possible limitation was that there are factors
unique to military women that have not yet been determined.
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The implication of this body of research by Agazio and Buckley (2010) was that
self-efficacy is highly predictive o f successful health-promoting behaviors. Therefore,
future healthcare interventions might include assisting in personal success recall
strategies, assisting with achievable goal-setting, and sharing of successful strategies
used by other women. The study also implicated that self-efficacy did not suffice on its
own; instead, tangible support proved to be necessary to implement goal-reaching
strategies. Interventions for this factor could be achieved at the organizational level by
improving policies relating to extended hours for childcare, flexible work hours, familyfriendly work environments, worksite health promotion programs, on-site health
facilities, and respecting non-work hours. Pender’s HPM guided the entire body of
research. Each individual aspect of the study was based on Pender’s model (Agazio &
Buckley, 2010).
In conclusion, Pender’s HPM was a solid model from which the student
researchers based their work. Its holistic approach was applied to the current research
and allowed the student researchers to carefully examine PCPs’ health promotion
strategies regarding opioid prescribing.
Review of Related Research
Review of research studies validated the necessity o f the research topic of the
student researchers. These research studies highlighted the importance o f primary care
providers’ compliance to opioid prescription guidelines as well as the need for
improved patient education regarding the consequences o f opioid overdose. These
studies also revealed providers’ views on naloxone prescription for opioid overdose
reversal.
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Decision to prescribe opioids. Harle et al. (2015) explored the decision
making processes of primary care providers for managing patients’ chronic pain with
opioids. Many providers struggle to provide effective pain management while avoiding
opioid misuse and abuse. According to the Institute o f Medicine, chronic pain is a
major burden on 100 million Americans annually. A lack of pain specialist physicians
results in the need for primary care providers to manage chronic pain. Primary care
providers also report frustration and hindrance in prescribing opioids due to lack of time
and minimal training in chronic pain management. In this study, Harle et al. sought to
determine if certain providers failed to use recommended guidelines due to lack o f time
and insufficient knowledge.
Harle et al. (2015) used qualitative interviews to conduct this study. The
locations were 9 medical facilities in rural and urban settings in the Gainesville and
Jacksonville areas of north central Florida. The providers, differing in age and
experience, volunteered for the study and submitted written informed consent.
Throughout the interviews, the providers discussed clinical information pertinent to
them when prescribing opioids for chronic pain. After the interviews, the researchers
identified 5 themes: (a) importance of objective and consistent information, (b)
identifying red flags, (c) significance of physical function and goals, (d) trust, and (e)
time constraints.
Each theme enlightened the researchers on the providers’ decisions to prescribe
or not to prescribe opioids. The first theme highlighted the issue o f inconsistency with
subjective versus objective information. Identifying red flags was an important theme
because these revealed patients’ tendencies to seek opioid treatment due to addiction.
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The third theme established goals for seeking pain management, and the fourth theme
addressed a provider’s “sense” o f a patient’s need for pain management. The fifth
theme developed due to providers’ lack of time during clinic visits based on patients’
comorbidities as well as chronic pain. After the study, Harle et al. (2015)
acknowledged the need for future research to develop and disseminate decision support
tools for prescribing opioids.
Harle et al. (2015) had strengths and weaknesses. Two strengths were
identified: (a) dissimilarity in age and experience of the providers and (b) differentiation
in practice specialty, location, and practice ownership. One weakness was the lack of
transferability o f decision-making approaches across different cultures and larger
international boundaries. Unfortunately, the study also had limitations due to the small
sample size consisting of providers only from only one state. As a result, the findings
o f Harle et al. (2015) did not reflect feelings and thoughts from provider groups in other
states. The limitations in the current study may mimic this study’s limitations due to
sample size and population.
Harle et al. (2015) related to the current research by addressing the issues
concerning opioid prescribing. While Harle et al. did not address any of the current
researchers’ research questions specifically, there was still enough information to
strengthen the researchers’ first question. This study explained that some providers
have difficulty abiding by such guidelines due to certain barriers. The findings in this
study strengthened the current researchers’ foundation for the first research question by
identifying providers’ decision-making processes for prescribing opioids. While the
current researchers may not directly respond to the challenge for future research, the
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study will strengthen the need for future researchers to disseminate decision support
tools and to provide education about managing chronic pain.
Opioid crisis and resolution. Wolfe, Bouffard, and Lowe (2016) discussed the
problem o f opioid overdoses. The Centers for Disease Control and Prevention stated
that too many physicians are prescribing opioids to patients who are in serious pain
without trying other methods first. Wolfe et al. (2016) wanted to discuss the problem of
opioid overdoses and provide information on how to reduce the number o f deaths from
opioid overdoses.
The main objective of Wolfe et al. (2016) was focusing on the administering of
naloxone (Narcan) to stop the effects of the opioid. The CDC labeled the epidemic of
opioid overdoses in 2012, but the problem has only gotten worse. One reason for the
growing epidemic is the availability of heroin in the U.S. Another reason is the
growing number of prescriptions being given to patients for pain. Many of the overdose
victims did not take the medication as prescribed or obtained the medication from
someone else to try and eliminate their pain. Wolfe et al. (2016) listed four
subcategories o f prescription medicine: pain relievers, tranquilizers, stimulants
(including Ritalin), and sedatives. About two thirds o f the misused prescriptions were
gotten from a friend or relative or were stolen. Wolfe et al. (2016) stated that in 2010
there were “enough prescriptions written annually for painkillers to medicate every
adult American around the clock for a month” (p. 326). Some people even believe that
the painkiller is safe because a physician prescribed it.
The population with the highest overdoses is non-Hispanic white males while
overdoses among women are increasing. West Virginia has the highest overdose rate.
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and North Dakota has the lowest. To reduce these numbers, the CDC recommends that
the naloxone be administered when an overdose is expected. Many argue that
prescribing naloxone to reduce the effects o f the opioid will only encourage the
continued use of the opioid. If a person stays off the opioid for 3 or more days, then the
tolerance that has been built up will be reduced. A smaller amount o f the opioid can
cause an even greater risk because the tolerance level has been reduced.
Wolfe et al. (2016) recommended that naloxone be administered to reduce the
effects o f an overdose by policemen, emergency responders, and hospital staff. Wolfe
et al. (2016) stated that anyone who administers the drug should be properly trained. A
Good Samaritan law was passed that allowed someone to call in a suspected overdose
victim without being charged with a crime involving drugs. The legislation from 2015
requires that anyone who might administer naloxone (e.g., physicians, physician
assistants, advanced practice registered nurses, and dentists) must take a one-hour
continuing medical education on safe opioid prescribing methods.
Specific guidelines were set forth by the CDC for prescribing opioids. These
guidelines recommend that a doctor should not start with opioid medication, and
alternative treatment should be tried first. The CDC also recommends setting a goal for
how long the opioid should be prescribed. An immediate release opioid should be used
instead o f an extended release form. The lowest possible dose should be given. The
physician should evaluate the benefits and the harm of the opioid medication. The
physician should also avoid the opioid prescription if there are risk factors o f an
overdose. A urine test should be taken before prescribing the opioid to determine if the

35

patient is on any other drug. Finally, the physician should check the prescription drug
monitoring system regularly.
Wolfe et al. (2016) was not based on studies that were conducted in a controlled
environment with set members. Wolfe et al. (2016) presented their beliefs on the use o f
naloxone and discussed the necessity of using the drug for overdose victims to reduce
the number o f deaths. Wolfe et al. (2016) presented the information clearly and
effectively and explained the steps to be taken in the event of a drug overdose and the
dosage o f naloxone which could be used. Wolfe et al. (2016) believed that physicians
prescribed opioids too often before trying other methods like exercise, relaxation
techniques, and others.
These authors were a knowledgeable group o f experts who had PhDs or medical
degrees, and they worked as mental health experts. Wolfe et al. (2016) realized the
mental associations that could cause an overdose— stress, anger, depression, etc. To
reduce the number of overdose deaths, Wolfe et al. (2016) encouraged physicians to be
careful about prescribing opioid medications and encouraged the physicians to try other
methods o f pain relief before prescribing opioids. O f course, Wolfe et al. (2016) did not
just advocate the use of naloxone, they also recommended treatment programs to reduce
illegal drug use or misuse involving prescription medicine.
Better approach to opioid prescribing. Canada, DiRocco, and Day (2014)
conducted a study to evaluate opioid-prescribing practices, providers’ attitudes toward
competent management of chronic non-cancer pain (CNCP) patients and knowledge
regarding prescribing opioids. Misuse o f prescription opioids is a major problem in the
U.S., and opioid overdose death rates are so high that the CDC declared it a problem of
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“epidemic” status in 2012. Canada et al. (2014) developed and implemented a new
electronic medical record-based protocol to improve opioid prescribing practices. This
protocol included an educational intervention for providers, standardization of
documentation, and standardization of management o f CNCP. The researchers tested
their protocol and found providers who adhered had higher satisfaction rates with
management of CNCP patients.
The apparent hypothesis for Canada et al. (2014) was that “a clinical protocol
for opioid prescribing could improve the care that physicians and staff were providing
to CNCP patients, as well as improve the satisfaction that clinicians felt in providing
this care” (Canada et al., 2014, p. 2). An additional stated goal was “to determine
whether this initiative would result in adherence to the protocol and improve provider
and staff knowledge and satisfaction with management of patients prescribed opioids
for CNCP” (Canada et al., 2014, p. 2).
Canada et al. (2014) performed this study within their own clinics (3 internal
medicine practices) at the University o f Pennsylvania, Division of General Internal
Medicine. Providers included attending physicians and nurse practitioners. Staff
members included were registered nurses, licensed practical nurses, medical assistants,
and patient service representatives. The study took place over one year. During this
time, the first 3 months consisted of educating the providers and staff, while the
remaining 9 months was the actual period of evaluation. Pre- and post-surveys were
conducted but were anonymous. A protocol was developed based on expert opinion
and best-practice guidelines. The goal was quality improvement. The protocol initiated
standardization o f documentation and management and required urine drug screenings
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(UDS) and Controlled Medication Agreements (CMA). A “smart set” was created to
streamline and standardize the documentation in the electronic medical record (EMR).
The protocol, “smart set,” and surveys were developed via monthly meetings of expert
anesthetists, pain management specialists, and psychiatrists who reviewed the latest
evidence-based practices and recommendations.
The method for the study by Canada et al. (2014) was comprised o f 4
components: the development o f the protocol, instruction for using the protocol, data
collection, and a monetary incentive for providers who followed the protocol. Included
in the study were patients with > 2 opioid prescriptions over 6 months; acute pain
conditions were excluded. The variables of interest were the different provider roles:
attending physicians, resident physicians, and nurse practitioners. Patient demographics
were also a variable.
The study by Canada et al. (2014) was measured by examining the compliance
levels, pre- and post-provider satisfaction, and pre- and post-knowledge. This was done
using paired t tests. Stata 11.2 was used to analyze the data. Compliance to the
protocol was measured by comparing the study year to the previous year in regard to
“number o f UD S’s ordered, number of chronic pain diagnoses on EMR problem lists,
and the number of office visits with CNCP patients” (Canada et al., 2014, p. 4).
Statistically significant findings were noted in all 3 practices with UDS orders increased
by 145%. Practice 1 had the greatest improvement at 430% (p < .05). Chronic pain
diagnoses saw increases o f 424% overall. Again, Practice 1 saw the greatest
improvement at 918% {p < .05). Statistically significant improvements o f attitudes
were seen in multiple categories o f the surveys. The knowledge portion of the survey
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for providers only saw a 15% increase (p < .05). However, knowledge for staff did
increase significantly.
Canada et al. (2014) discussed the implications of the study and stated,
“By increasing adherence to best practice standards, we believe this protocol will lead
to improved management o f patients with CNCP by providing objective urine data to
guide a treatment plan, patient education with the CMA, and a documented evaluation
and care plan” (p. 7).
Limitations o f the study included educational background of practitioners, years
o f experience of practitioners, analysis of patient data on safety, abnormal lab results,
and patient outcomes related to interventions. Canada et al. (2014) believed a more
comprehensive study was warranted to determine better outcomes for patients and
improve patient safety.
Initial development of patient-reported instruments. Jenkinson and Ravert
(2013) conducted a quantitative and qualitative research citing that opioid abuse is a
global issue affecting both industrialized and developing countries. This study found
that 13.7% o f patients admitted to misuse or abuse o f opioid prescriptions by primary
care providers at some point in their lifetime. Nurse practitioners (NPs) have become
sole providers to underserved communities and give more health advice compared to
physicians who write prescriptions without proper screening. Under current legislation
laws in the U.S., NPs are prohibited from prescribing opioids which could help lessen
the gap to increased opioid prescription writing.
Jenkinson and Ravert (2013) hypothesized one goal o f office-based treatment of
opiate dependence was to evaluate how providers stay compliant with the CDC’s latest
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guidelines for opioid prescribing. Understanding current guidelines, providers are now
attempting to replace those who have an opioid addiction with methadone; however, the
increasing problem continues to rise due to underutilized programs for proper guidance
and treatment option, especially in rural areas.
According to Jenkinson and Ravert (2013), the CDC estimated billions were
spent on costs associated with prescription opiate addiction (POA) in 2005 with an
estimated rise since 2010. This escalation places opioid addiction second to marijuana
use. Naloxone, an opioid antagonist, received Food and Drug Administration (FDA)
approval to help curtail addiction in case of overdose. The efficacy has proven a
successful outcome for those who were compliant. Extensive empirical evidence
demonstrates that naloxone is safe and effective for treatment o f opioid addiction in the
primary care setting. Prescription opiate users usually have better outcomes with
overuse because they come from a more stable environment and the addiction may not
be as severe.
Weaknesses in this research, according to Jenkinson and Ravert (2013),
indicated lack o f experience or training by physicians was the most significant barrier.
The next weakness was limited access to sufficient education or screenings prior to
opioid initiation. Primary care physicians (PCP) face overcoming barriers that affect
those who need treatment the most; however, nurse practitioners have legal authority to
identify how they can control their chronic and harmful addiction.
Jenkinson and Ravert identified that office-based treatments were being unmet
due to lack o f screening for opioid addiction which causes potential problems to
becoming addicted rather than being evaluated for treatment to help the addiction.
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According to Jenkinson and Ravert (2013), goals were not met with current system to
monitoring monthly prescriptions for pain management or other symptoms.
Statistically, NPs deal with POA in primary care settings and have been providing
excellent care with positive outcomes for patients who have a chronic problem.
Jenkinson and Ravert (2013) indicated that NPs have received the highest patient
satisfaction scores because they usually provide more health advice when compared to
physicians to individuals who need the prescriptions but may be limited due to the
awareness o f the rising problem.
Regional variance. Paulozzi, Mack, and Hockenberry (2012) presented
findings to the CDC’s Morbidity and Mortality Weekly Report in July 4, 2014, which
showed variation in prescription rates of opioids and benzodiazepines among states in
the U.S. The study was conducted due to the prevalent, imminent threat o f opioid
misuse and overdose. As reported by the CDC in 2011, there were 16,917 deaths
resultant o f opioid overdose. Opioid-prescribing can present as a double-edged sword
in that opioids are highly effective in treating pain, though highly addictive with
potentially life-threatening side effects. Paulozzi et al. found that opioid pain relievers
were more frequently prescribed among southeastern states. The study referenced other
studies in which the former researchers could find no discernible explanation to the
variance among states in opioid prescription. No theoretical framework was identified
in the study. The study posed no hypothesis or research questions, though the purpose
was clearly to determine variance among opioid prescribing practices among the states
in America. The study also included benzodiazepine prescription rates; however, the
current researchers focused solely on prescribing rates of opioids.
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The study collected data on prescribing in 2012 from IMS Health’s National
Prescription Audit (NPA). The NPA provides estimates in each state by pooling
opioids dispensed from retail pharmacies which accounts for approximately 80% of
prescriptions in the U.S. The CDC then calculated prescribing rates per 100 persons for
the U.S., each region, and each state. Paulozzi et al. (2012) found that prescribing rates
were highest in Alabama, Tennessee, West Virginia, Kentucky, Oklahoma, and
Mississippi, respectively. Paulozzi et al. found that prescribing rates were lowest in
Hawaii, California, New York, Minnesota, New Jersey, and Alaska, respectively. The
rates demonstrated a three- to fivefold variance from the highest to lowest states.
Paulozzi et al.’s (2012) study has strength and validity in demonstrating a
difference among states in opioid prescription rates, though leaving a need for
interpretation of the rationale for such difference. The researchers suggested that the
gradient could not be explained by an underlying health disparity among the states—
rather that it may be due to a lack o f consensus among healthcare providers. Though
several studies have found no correlation between regional health status and the rates of
opioid prescription, it cannot be dismissed as a plausible explanation. Many o f the
regions with the highest rates of opioid prescription are known to have a greater
prevalence of physical ailments linked to pain— most notably obesity.
Perhaps, the most definitive research to prove, disprove, or at least suggest a
correlation between regional comorbidities and opioid prescription would be regional
chart audits. Audits could aid in examination of the patient’s presentation and
comorbidities as well as the provider’s adherence to guidelines in opioid prescription.
Thus, this presents pertinence to the current research in which chart reviews were used
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to examine patient presentation and adherence to guidelines. According to data
obtained in the current research, Mississippi has the 6th highest rate of opioid
prescription.
Overdose education and naloxone prescription. Binswanger et al. (2015)
conducted a study to investigate the use o f naloxone distribution in the primary care
setting. Binswanger et al. also delved into the beliefs and attitudes of those primary
care providers about overdose and overdose education. The background o f the study
consisted of information regarding the unintentional overdose of opioid medications.
The numbers o f overdose have continually risen since the 1990s, but naloxone is an
effective antagonist to these harmful side effects. Primary care providers represent a
large number of providers able to educate patients regarding overdose and naloxone
education. Binswanger et al. used the Theory o f Planned Behavior and the Health
Belief Model as theoretical frameworks for the study.
The study was conducted from August 2013 and October 2014 with 56
participants taking part in 10 focus groups. O f the focus group participants, each group
had at least one prescriber, such as a nurse practitioner, physician, or physician
assistant. The goal o f the study was to determine information in the following content
areas: knowledge, barriers, benefits, and facilitators. The setting of the study took place
in 3 large Colorado health systems that included family medicine, infectious
disease/HIV practice, and primary care internal medicine. The results of focus groups
were digitally recorded, and the results were used to analyze themes using both
inductive and deductive analysis.

43
Binswanger et al. (2015) chose to divide information into 4 content areas that
included knowledge, barriers, benefits, and facilitators. The first content of knowledge
found that most primary care providers did not have proper information of outpatient
naloxone-prescribing, and many had not used the drug since their training days. The
study also found that many of the providers were not aware if their patients had
overdosed in the past. Binswanger et al. also stated that they were not knowledgeable
enough about naloxone to feel comfortable about prescribing it to their patients. The
results o f the study identified several high-risk patient groups including those prescribed
high-dose opioids or benzodiazepines, history of or predisposition of substance abuse
disorders, or those with mental health disorders noted as the top 3 areas. The focus
groups also identified barriers to the outpatient use of naloxone that included time
consumption, difficulty in initiating conversations about overdose, lack of
confidentiality with bystander training, patient cost and training, and the pharmacy
availability o f naloxone to the patient and pharmacy.
The benefit that was identified through this study by Binswanger et al. (2015)
was the decrease o f death with naloxone use. Binswanger et al. also identified areas
that would need to be set up prior to implementing the use o f naloxone, such as protocol
for prescribing and plans for what to do after the administration of naloxone in the
outpatient setting. Future research included in the study suggested that research needs
to be implemented for patient satisfaction with the idea of naloxone administration.
Future research also should determine if naloxone promotes risk compensation.
Binswanger et al. (2015) also discussed the need to research the true effectiveness of
naloxone in the outpatient setting.
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CHAPTER III
Methodology
The purpose of this study was to determine if primary care providers in
Mississippi were compliant with the CDC’s latest guidelines for opioid prescribing.
Opioid overdose deaths have increased exponentially in recent years, and opioid
prescribing practices have become a growing area of concern (Doyon et al., 2014).
Mississippi has very high opioid prescribing rates, when compared to the national
average (MSDH, 2016). Therefore, the student researchers examined opioidprescribing practices in Mississippi to determine the most recent guideline adherence
rates. This body o f research first focused specifically on 3 key elements o f the current
CDC guidelines: (a) prescribing nonopioid treatments first, (b) avoiding concurrent
prescribing of opioids and benzodiazepines, and (c) checking urine drug screens prior to
opioid initiation and then annually. The secondary focus of the research was
determining whether PCPs in Mississippi were prescribing naloxone for opioid
overdose reversal, as recent research has shown naloxone to be highly effective as a
life-saving treatment for opioid overdose (Wheeler et al., 2015). Finally, the
researchers examined whether PCPs in Mississippi provided sufficient patient education
related to opioids. The student researchers assumed that, through patient education,
adherence to CDC guidelines, and naloxone prescribing, patients would have reduced
risk o f opioid overdose and misuse.
Design of the Study
A nonexperimental, quantitative, descriptive, retrospective review o f charts in 6
primary care clinics in the southeastern United States was conducted to evaluate
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adherence to the CDC guidelines o f opioid-prescribing by primary care providers. A
convenience sampling o f 600 charts for retrospective chart review was conducted. All
chart reviews were conducted within each clinic; no charts were removed from the
clinics for the purpose of this study. This design type was beneficial due to the
accessibility o f charts for review, limited time to obtain data, and the ability to preserve
anonymity of the individual patient.
Setting for the Research Project
The setting for the research project was primary care clinics in the southeastern
region o f the U.S. More specifically, the student researchers collected data from 6
clinics in Mississippi staffed by physicians and nurse practitioners. The clinics were in
the following regions: east central, west central, and northeast Mississippi.
Population and Sample
The population considered for this study included men and women above the
age of 18 years, o f all ethnicities and socioeconomic statuses, and formally diagnosed
with chronic pain. Inclusion criteria were as follows: (a) age 18 years or older, (b)
medically treated chronically with opioids (defined as 2 or more opioid prescriptions
written >21 days apart) for CNCP, and (c) prescribed by a PCP (physician or nurse
practitioner). Oncology patients, except non-melanoma skin cancer and prostate cancer
patients, were excluded from the study. A random convenience sampling o f 600
medical records was selected for the purposes o f chart review in this study. The chart
selection included the ICD-10 diagnosis codes G89.2 chronic pain (not elsewhere
classified), G89.21 chronic pain due to trauma, G89.22 chronic post-thoracotomy pain,
G89.28 other chronic post-procedural pain, G89.29 other chronic pain, G89.4 chronic
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pain syndrome, R52 pain unspecified, M25.5 pain in joint, M25.50 pain in unspecified
joint, M25.51 pain in shoulder, M25.52 pain in elbow, M25.53 pain in wrist, M25.54
pain in joints o f hand, M25.55 pain in hip, M25.56 pain in knee, M25.57 pain in ankle
and joints of foot, M54.2 cervicalgia, M54.9 dorsalgia, M54.5 low back pain, M54.6
pain in thoracic spine, M79.60 pain in limb, M79.62 pain in upper arm, M79.63 pain in
forearm, M79.64 pain in hand and fingers, M79.65 pain in thigh, M79.66 pain in lower
leg, or M79.67 pain in foot and toes. For this research, 6 primary care clinics were
chosen; 100 charts were reviewed from each of the clinics. The clinics are in rural areas
as well as some more urban settings o f Mississippi. Site A is an internal medicine clinic
with a single MD provider treating adults only for acute and chronic illnesses. Site B is
a family medical clinic which employs 3 providers (1 MD and 2 NPs). This clinic treats
patients from 4 months and older. Site C is a federally-funded facility with 2 MDs, 3
FNPs, 1 PNP, and 1 DMD. This site treats patients from birth throughout the lifespan.
Site D is a family medical clinic with 1 MD and 3 NPs. This facility treats patients
from age 2 months and older, acute and chronic illnesses, and women’s health. Site E is
a combination family practice and urgent care clinic with 1 MD who treats acute and
chronic illnesses from age 6 months and older. Site F is a regional health system
employing 14 MDs, 7 DOs, and 2 NPs. This site treats adults for acute and chronic
illnesses.
Clerical staff from each primary clinic pulled charts that were specific to the
criteria for this study. From those, 100 charts were chosen for review per researcher.
Each chart was reviewed using a data collection worksheet to determine prescribing
practices with regard to opioids. These charts were reviewed in a legal and ethical
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manner, with no interaction with patients. The charts were reviewed using the latest
CDC guidelines for opioid-prescribing in Mississippi.
Methods of Data Collection
Prior to conducting the study, consent was obtained from the Institutional
Review Board (IRB) at the Mississippi University for Women (see Appendix A). After
consent from the IRB was obtained, each research team member contacted his or her
respective clinic manager and obtained consent to perform a chart review to obtain data
(see Appendix B). Each member reviewed the charts pulled by office staff in a random
convenience sample of 100 charts. The Opioid and Naloxone Prescribing Practices
Data Collection Worksheet was utilized by each member to collect the data (see
Appendix C). Once the data collection was completed, each researcher compiled their
respective data into a single word processing spreadsheet. These data were stored on a
password-protected USB drive. There was no patient interaction for data collection.
Methods of Data Analysis
The collected data were compiled into a word processing document. These data
were then analyzed to determine if primary care providers were adhering to the CDC’s
guidelines for administration o f opioid pain medications and if they were prescribing
Narcan for patients who were prescribed opioid pain medications for patients 18 years
o f age or older with chronic, non-cancer pain. After data collection, the data were
subjected to analyses using descriptive statistics including, but not limited to, frequency,
distributions, and percentages.
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CHAPTER IV
Presentation of Findings
Drug overdoses have increased in the last 3 decades in the U.S. (Doyon et al.,
2014). The purpose of this study was to determine if primary care providers in
Mississippi are compliant with the CDC’s latest guidelines for opioid prescribing. The
student researchers examined opioid-prescribing practices in Mississippi to determine
the rates o f adherence to the guidelines. The primary focus o f this research was 3 key
elements of the current CDC guidelines: (a) prescribing nonopioid treatments first, (b)
avoiding concurrent prescribing o f opioids and benzodiazepines, and (c) checking urine
drug screenings prior to opioid initiation and then annually. The secondary focus of the
research was determining whether PCPs in Mississippi were prescribing naloxone for
opioid overdose reversal as recent research has shown naloxone to be highly effective
as a life-saving treatment for opioid overdose (Wheeler et al., 2015). Finally, the
researchers examined whether PCPs in Mississippi provided patient education related to
opioids and overdose. Nonexperimental, quantitative, descriptive, retrospective review
o f charts in 6 primary care clinics in the southeastern United States was conducted to
evaluate adherence to the CDC guidelines of opioid-prescribing by primary care
providers.
A convenience sampling of 600 charts was conducted by performing a
retrospective chart review. The Opioid and Naloxone Prescribing Practices Data
Collection Worksheet was utilized by each member to collect the data. This chapter
describes the study’s sample. This chapter also answers the research questions by
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applying the findings from the study and discusses the profile of study participants.
Statistical results are summarized in figures.
Profile of Study Participants
Data for the research study were collected by method of convenience sampling.
A retrospective chart review was performed on 100 charts from 6 clinics in the
southeastern United States. Each researcher drew their sample from a different clinical
site. The sample included patients 18 years or older with an active diagnosis of chronic,
non-cancer pain. Cancer patients, with the exception o f non-melanoma skin cancer and
prostate cancer, were excluded from the sample. Acute pain was also excluded from the
sample. The sample was used to examine provider adherence to the most recent CDC
Guidelines for Opioid Prescribing.
If treatment was initiated before the guidelines were released, the following
categories were marked as not applicable'. Nonpharmacologic therapy initiated prior to
opioids, nonopioid therapy initiated prior to opioids, and urine drug screen performed
prior to initiation o f opioids. If there was clear documentation o f these criteria being
met, however, it was included in the findings. The selected charts represent patients
that were 18 years and older with an active diagnosis of chronic, non-cancer pain. The
selection was made after the CDC guidelines were published in March of 2016;
therefore, the sample population only included patients treated from March 2016
through May 2017. At each clinical site, a random convenience sampling of 100
medical records was selected for the purposes o f chart review in this study. Five of 6
clinical sites utilized EMRs, while one clinic still utilized paper charting. The EMRs
were selected by searching for the ICD -10 criteria. The paper charts were chosen by

50
random selection of charts until 100 pain patients were identified. The chart selection
included the following ICD-10 pain diagnoses: G89.2 chronic pain not elsewhere
classified, G89.21 chronic pain due to trauma, G89.22 chronic post-thoracotomy pain,
G89.28 other chronic post-procedural pain, G89.4 chronic pain syndrome, R52 pain
unspecified, M54.5 low back pain, M54.6 pain in thoracic spine, or G89.29 other
chronic pain. Demographic information extracted included age and gender. Other
information documented from the charts included provider type and ICD-10 pain
diagnoses.
Age. The research sample consisted of individuals ranging in age from 25 years
to 94 years old.
Gender. The sample population was comprised of more females than males.
The gender distribution was 45% male {n = 267) and 55% female (/? = 332). Figure 1
represents the gender distribution among the sample population.

Gender

Males

45%
Females
55%

Figure 1. Percentage of gender distribution in the sample population.

Males
Females
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Provider type. The researchers determined the type o f prescribing provider
while collecting their data. O f the sample population, 65% of providers were Doctors
of Medicine (/? = 388), 29% were Nurse Practitioners (n = 177), and 6% were Doctors
of Osteopathic Medicine (n = 34). Figure 2 represents the distribution of provider types
amongst the sample population.

Provider Type

Figure 2. Percentages of opioid-prescribing providers.

Statistical Results
A random convenience sampling of 600 medical records were reviewed to
complete this retrospective chart review. Inclusion criteria were as follows: (a) age 18
years or older, (b) medically treated long-term with opioids (defined as 2 or more opioid
prescriptions written > 21 days apart) for chronic non-cancer pain, and (c) prescribed by
a PCP (physician or nurse practitioner). The Opioid and Naloxone Prescribing
Practices Data Collection Worksheet was utilized by each member to collect the data.
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The researchers entered all statistical information from the data collection worksheets
into a Microsoft Excel spreadsheet and formulated to determine n = number for each
category. The researchers investigated the following research questions:
1. Are primary care providers in Mississippi compliant with the following
selection of the CDC’s latest guidelines for prescribing opioids for chronic
pain in Mississippi?
a. Nonpharmacologic therapy or nonopioid pharmacologic therapy first.
b. Avoid concurrent prescribing o f opioids and benzodiazepines.
c. Check urine drug screen prior to opioid initiation and then annually.
2. Are primary care providers in Mississippi prescribing naloxone for opioid
overdose reversal?
3. Do primary care providers provide education to patients regarding opioid
overdose?
Research question 1. Are primary care providers in Mississippi compliant with
the following selection o f the CDC’s latest guidelines for prescribing opioids for
chronic pain in Mississippi?
a.

Nonpharmacologic therapy or nonopioldpharmacologic therapy first. The

researchers determined if primary care providers used nonpharmacologic therapy or
nonopioid pharmacologic therapy before prescribing opioids. After performing a
random convenience sampling o f 600 medical records, the researchers found the
following: O f the 600 charts reviewed, 9% o f the patients were prescribed
nonpharmacologic therapy first (/? = 54), 12% o f the patients were not prescribed
nonpharmacologic therapy first (/? = 70), and 79% of the selected charts were classified
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as not available (n = 475), as initiation o f therapy was prior to initiation o f the CDC
guidelines. O f the 600 charts reviewed, 26% of the patients used nonopioid therapy
first (n = 156), 14% of the patients did not use nonopioid therapy first (n = 84), and in
60% o f the selected charts this information was not available (n = 360).
b. Avoid concurrent prescribing o f opioids and benzodiazepines. The
researchers determined if primary care providers avoided concurrent prescribing of
opioids and benzodiazepines. After performing a random convenience sampling o f 600
medical records, the researchers found the following: O f the 600 charts reviewed, 20%
o f the patients were prescribed opioids and benzodiazepines concurrently {n = 120) and
80% of the patients were not prescribed opioids and benzodiazepines concurrently {n =
479).
c. Check urine drug screen prior to opioid initiation and then annually. The
researchers determined if primary care providers checked a urine drug screen prior to
opioid initiation and annually. After performing a random convenience sampling of
600 medical records, the researchers found the following: O f the 600 charts reviewed,
20% o f the patients had urine drug screens (n = 120) and 80% o f the patients did not
have urine drug screens {n = 479).
See Figures 3-6.
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N onpharm acologic

Yes

No
N/A

Figure 3. Percentage of patients prescribed nonpharmacologic therapy first.

Non-Opioid
Yes
26%

Yes
No
N/A

60 %

Figure 4. Percentage o f patients prescribed nonopioid therapy first.

N/A
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Concurrent Benzodiazepines

Figure 5. Percentages of patients concurrently prescribed opioids and
benzodiazepines.

Urine Drug Screen

Figure 6. Percentages o f patients with urine drug screens prior to opioid
initiation and then annually.
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Research question 2. Are primary care providers in Mississippi prescribing
naloxone for opioid overdose reversal? The researchers determined if primary care
providers prescribed naloxone therapy for opioid overdose reversal when prescribing
opioids. After performing a random convenience sampling of 600 medical records, the
researchers found the following: O f the 600 charts reviewed, 0% of the patients were
prescribed naloxone therapy (n = 0) (see Figure 7).

Naloxone Prescribed

100 %

Figure 7. Percentage of patients that received naloxone therapy.

Research question 3. Do primary care providers provide education to patients
regarding opioid overdose? The researchers determined if primary care providers gave
education regarding opioid overdose before prescribing opioids. After performing a
random convenience sampling of 600 medical records, the researchers found the
following of the 600 charts reviewed: 48% of those patients did receive education
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regarding opioid overdose (n = 286) and 52% did not receive education regarding
opioid overdose (/? = 314) (see Figure 8).

Opioid Education Provided

Figure 8. Percentages of patients who were educated about opioid overdose.
Summary of Findings
Chapter IV presented the researchers’ findings from the retrospective review of
600 patients from 6 clinics in the southeastern United States. Findings from the
demographics and research questions were presented in figures. The results of this
analysis revealed noncompliance among primary care providers regarding the
prescription of nonpharmacologic and nonopioid therapy first. The results also revealed
that most primary care providers did avoid concurrent prescribing of opioids and
benzodiazepines, and most of the primary care providers were noncompliant with urine
drug screens prior to opioid initiation and annually. Furthermore, primary care
providers in the selected clinics did not prescribe naloxone for opioid overdose reversal.
Finally, the results revealed that < 50% o f the patients received education regarding
opioid overdose. These conclusions highlight the opportunity for improvement among
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primary care providers, especially nurse practitioners, regarding opioid prescribing
practices. Figure 9 represents the overall adherence to CDC guidelines and naloxone
prescribing practices per individual guideline.
0CDC Opioid Guideline Adherence
350

Jr.

^ >

■ Non-Pharmacologic
■ Non-Opioid
■ Concurrent Benzo
■ Urine Drug Screen
■ Naloxone
■ Opioid Education

Figure 9. Summary o f reviewed charts in compliance with CDC opioid-prescribing
guidelines and naloxone prescribing practices.
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CHAPTER V
Summary and Conclusions
The study determined whether the selected primary care providers were
following CDC guidelines for prescribing opioids and whether providers were
prescribing naloxone for opioid overdose reversal. The study also sought to determine
if the selected primary care providers were providing education regarding the risks of
opioids, as well as education about naloxone, if prescribed. Hydrocodone and
oxycodone continue to be the most numerous prescriptions written according to the
MSDH in 2016, and they continue to be the leading cause o f unintended overdoses and
death o f many individuals. Many o f the overdoses are not only resulting from opioids
smuggled into the country, but additionally as a result of indiscriminate opioid
prescribing by healthcare providers.
The research project allowed knowledge expansion of opioid overdose and
providers’ prescribing habits. The research group formulated questions based on the
CDC guidelines for treatment of chronic, non-cancer pain which were published in
March o f 2016. The purpose of the research project was to determine compliance with
the selected guidelines. The secondary goal was to determine the need for increased
education among providers regarding opioid treatment o f chronic, non-cancer pain.
Compliance was evaluated by the following research questions:
1. Are primary care providers in Mississippi compliant with the following
selection of the CDC’s latest guidelines for prescribing opioids for
chronic pain in Mississippi?
a. Nonpharmacologic therapy or nonopioid pharmacologic therapy first.
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b. Avoid concurrent prescribing o f opioids and benzodiazepines.
c.

Check urine drug screen prior to opioid initiation and then annually.

2. Are primary care providers in Mississippi prescribing naloxone for opioid
overdose reversal?
3. Do primary care providers provide education to patients regarding opioid
overdose?
The research was guided by previous studies related to the opioid epidemic. An
overview o f the literature review is as follows. According to Venes (2013), chronic
pain is the leading cause o f disability. Harle et al. (2015) found that a lack o f pain
specialists has resulted in the need for primary care providers to manage chronic pain
although effective management is often challenging. Wolfe et al. (2016), in reference to
the CDC, found that too many physicians are prescribing opioids without trying other
methods first. Canada et al. (2014) developed and implemented a new EMR-based
protocol to improve opioid prescribing practices. Canada et al. determined their EMRbased protocol increased adherence to best practice standards and led to safer and more
effective management o f chronic, non-cancer pain (Canada et al., 2014). Finally,
according to Jenkinson and Ravert, naloxone has been approved by the FDA for use in
the primary care setting. These previous studies established a foundation to guide the
principles of this study.
A random convenience sampling of 600 medical records were reviewed to
complete this retrospective chart review. Inclusion criteria were as follows: (a) age 18
years or older, (b) medically treated long-term with opioids (defined as 2 or more opioid
prescriptions written > 21 days apart) for chronic non-cancer pain, and (c) prescribed by
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a PCP (physician or nurse practitioner). Data were collected and analyzed in the results
section and will be discussed in the following sections: Summary and Discussion of the
Findings, Conclusions, Implications, Limitations, and Recommendations.
Summary of the Findings
The sample project consisted o f 600 participants. The participants received care
at 6 primary care clinics in the southeastern United States between March 2016 and
May 2017. The sample consisted o f 45% (/? = 267) males and 55% (n = 332) females.
The age ranges were from 25-94 years. O f the charts reviewed, 0% of the patients were
prescribed naloxone therapy (n = 0) for emergent opioid overdose reversal. O f the
charts reviewed, 48% o f the patients received education regarding opioid overdose (n =
286) and 52% did not receive education regarding opioid overdose (n =314). O f the
charts reviewed, 9% o f the patients utilized nonpharmacologic therapy first (n = 54),
12% o f the patients were not treated by nonpharmacologic therapy first (n = 70), and in
79% o f the selected charts, this information was not applicable (n = 475). O f the charts
reviewed, 26% o f the patients used nonopioid therapy first (n = 156), 14% of the
patients did not use nonopioid therapy first (n = 84), and in 60% o f the selected charts,
this information was not applicable {n = 360). O f the charts reviewed, 20% of the
patients were prescribed opioids and benzodiazepines concurrently (n = 121) and 80%
o f the patients were not prescribed opioids and benzodiazepines concurrently (n = 479).
O f the charts reviewed, 20% of the patients had urine drug screens (n = 120), and 80%
o f the patients did not have urine drug screens (n = 479). O f the sample population (n =
600), 65% of providers were Doctors o f Medicine (n = 388), 29% were Nurse
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Practitioners (n = 177), and 6% were Doctors of Osteopathic Medicine (n = 34) o f the
sample population.
Discussion o f the Findings
Many o f the charts reviewed were o f patients who were prescribed opioid
therapy for chronic, non-cancer pain prior to the March 2016 publication of the CDC
guidelines for prescribing opioids for chronic pain, thus data prior to the date of
publication were excluded from the study. Since prior data were excluded, it cannot be
determined if the patient was treated with nonpharmacologic and/or nonopioid therapy
prior to initiation of opioid therapy; in these instances, findings were labeled as not
applicable. Approximately 43% of the applicable 178 charts reviewed were prescribed
nonpharmacologic therapy prior to opioid therapy {n = 54). O f the 396 applicable
charts reviewed, 65% were prescribed nonopioid therapy prior to opioid therapy (/? =
156). O f the 600 charts reviewed, 20% of patients were prescribed opioids and
benzodiazepines concurrently (/? = 120). O f the 600 charts reviewed, 20% o f patients
had a drug screen in compliance with the CDC guidelines, i.e. a drug screen prior to
opioid treatment and an annual drug screen thereafter (n = 120). The researchers found
that of the 600 charts reviewed, none of the patients received naloxone therapy {n = 0).
This is most likely due the cost o f prescription naloxone. The cost of a naloxone auto
injector ranges from $2,250 to $2,460 out-of-pocket and coverage varies among health
insurance companies. However, this may also be attributed to common practice, as well
as the fear that prescribing naloxone will lead to more risky use o f opioids by patients.
The researchers found that 48% o f the charts reviewed received education regarding the
risks of opioids {n = 288).
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A random, convenience sampling of 600 medical records were reviewed. The
sample population was comprised of more females than males. The gender distribution
was 45% male (/? = 267) and 55% female {n = 332). There was no statistical
significance between gender and opioid-prescribing practices. O f the sample
population, 388 o f providers were Doctors o f Medicine, 177 were Nurse Practitioners,
and 34 were Doctors of Osteopathic Medicine. There was no statistically significant
effect on prescribing practices between the 3 provider types evaluated.
Conclusions
The purpose of this study was to determine if primary care providers in
Mississippi were treating chronic, non-cancer pain in accordance with the CDC
guidelines for prescribing opioids. The study evaluated the charts o f patients 18 years
o f age or older. The study design was a retrospective chart review o f 600 charts that
were selected based on applicable chronic pain diagnoses in patients treated with
opioids. The most recent CDC guidelines were published in March 2016, and all data
prior to that date were excluded from the study. Based on the research data, the
majority of primary care providers in Mississippi were not consistently following CDC
guidelines for opioid prescribing. The data were collected within the first year after the
2016 CDC guidelines were published, so it is plausible that the primary care providers
were unaware of the changes in approach to managing chronic, non-cancer pain.
However, it should be noted that ignorance is not accepted by governing bodies, such as
the Board o f Medicine, the Board o f Nursing, and the Drug Enforcement Agency
(DEA). The researchers concluded that primary care providers in Mississippi
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demonstrate a need for heightened awareness and education regarding the CDC’s
guidelines for opioid-preseribing.
Implications
The incidence o f opioid-related overdose and death has continuously risen to
unprecedented levels, which led to the investigation of the epidemiology of the
aforementioned trend. The problem has gained attention of multiple federal and state
agencies, such as the DEA and the CDC. In March of 2016, the CDC released new
guidelines by which healthcare providers should approach chronic, non-cancer pain
management. The guidelines have been accepted as best practice by both the Board of
Medicine and the Board o f Nursing. While the new guidelines are not rule, regulation,
or law, prudent medical judgment should be carefully considered when prescribing
outside the CDC recommended criteria. As the CDC guidelines continue to be
disseminated, healthcare providers are still finding themselves in the crosshairs of legal
fire for failure to adhere to certain guidelines. Some states are enacting new stricter
prescribing laws that align with the CDC guidelines in an effort to curb the opioid crisis.
As the CDC guidelines continue to be disseminated, it is advised that healthcare
providers should practice in compliance with the CDC guidelines for management of
chronic, non-cancer pain.
This research project yielded findings that are ineongruent with evidence-based
best practice as outlined in the CDC Guidelines for Opioid Prescribing. The
implications are that nonadherence continues to place patients at risk. Furthermore,
nonadherent healthcare providers are at risk of losing their credentials and licensure.
These providers are also at risk for financial penalties and potentially criminal charges.
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Nola Pender’s HPM should serve as a standard that nurse practitioners use in treating
chronic, non-cancer pain. The evidence demonstrates the risks associated with
nonadherence to the CDC guidelines. The CDC guidelines are evidence-based and
congruent with the HPM. The HPM is designed to promote health through prevention
and promotion o f health-conscious behaviors. Nola Pender described nursing as “the
science and art of helping people change their lifestyle to move toward a state of
optimal health” (Alligood, 2014, p. 303). Thus, the goal of the nurse practitioner, as
well as other healthcare providers, is to promote optimal health by recognizing the risks
of opioids and utilizing best practice in regard to managing chronic, non-cancer pain as
outlined by the CDC.
Limitations
Limitations readily identifiable prior to performing data collection were
identified as small sample size, geographically limited data collection, and the use of
convenience sampling. As recognized in the methodology section of this study, data
were obtained by performing a retrospective chart review from 6 primary care clinics in
Mississippi. The population ranged from central and east central Mississippi to north
Mississippi. Data were collected and analyzed from a sample of 600 charts. The study
was designed to examine the opioid and naloxone prescribing practices o f primary care
providers.
The sample size o f 600 charts was relatively small and potentially decreased the
reliability o f generalizing to the entire populous. The study could be replicated to
obtain a larger sample size. The larger sample would most likely represent the actual
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trend in prescribing practices. Obtaining information from a larger sample consisting of
multiple states across the nation would also be beneficial.
The study was geographically limited and unlikely represented prescribing
practices across the nation. A similar study was conducted in which the findings
suggested a threefold to fivefold variance among states in the U.S. in rates of opioidprescribing (Paulozzi et al., 2014). Paulozzi et al. (2014) found that Mississippi had the
6th highest opioid prescription rates; this was the trend among multiple southeastern
states.
The final limitation known prior to data collection was the use of convenience
sampling. As it pertains to research, convenience sampling is the weakest form of
sampling. Convenience sampling is often a beginning point to lead to further research.
In this study, data were obtained from a random sample o f charts. This method may not
represent the entire population o f the clinic nor is it likely to provide strong assumptions
o f other clinics. However, the method o f chart review may be stronger than data
obtained by volunteers.
During data collection and analysis, the researchers recognized that many o f the
populations sampled were established chronic, non-cancer patients that began treatment
prior to the implementation o f the CDC guidelines in March 2016. Therefore, several
parameters could not be analyzed and were marked as not applicable. Those
nonapplicable parameters were identified as implementation of nonpharmacologic and
nonopioid therapy prior to opioid initiation as well as an initial urine drug screen.
Furthermore, the study may have yielded skewed results due to the relatively short
timeframe between data collection and dissemination of the new guidelines.
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Recommendations
The researchers recommend that this study be replicated with a larger population
throughout multiple regions in the United States. The researchers also recommend that
the study be replieated annually to determine if there was an increase in adherence to
the CDC guidelines. The timeframe for a newly established guideline to be
implemented into common practice is typically 2 years. This amount of time should
pass before replicating the study. Therefore, the spring of 2018 would be an appropriate
delay before a new set o f data could be obtained to analyze. This particular research
design could be replicated exactly to determine if there was increased adherence in the
same region. Any future study should also evaluate if an increase in naloxone
prescription occurs. The researchers recommend correlating adherence to the
guidelines with the incidence o f opioid-related overdose and deaths.
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APPENDIX B
Letter of Consent
DATE:
SUBJECT : Permission to Participate in a Quality Assurance Research Study
We are graduate students at Mississippi University for Women in the Family Nurse
Practitioner program in Columbus, MS. As a program requirement, we are conducting
a retrospective chart review to assess primary care provider compliance to opioid
prescription guidelines set forth by the Centers for Disease Control and Prevention
(CDC). The students that are participating in this research project are Rebecca Brown,
Brittany Clayton, Alissa Damiens, Natalie Keyes, Gary Adam McPherson, and Anna
Elizabeth Wiygul.
We are requesting your permission to utilize your clinic as one of the settings for our
study. By providing us with permission, we will have access to your patients’ medical
records for a retrospective chart review. We recognize the essential need for
confidentiality in regard to patient health information. Each student has completed a
HIPAA training workshop through Mississippi University for Women. The students
further agree to protect all information obtained, and no identifying information will be
recorded. We will be utilizing a student-designed data collection worksheet to collect
the required information. A copy of this tool is included with this letter. We will
transcribe the data directly from the chart to the data collection form, thus no patient
identifiers will be removed from the clinic. No identifying personal, provider, or clinic
information will be included. A complimentary copy of the study results will be
provided to all participating clinics.
If you have any questions concerning this research study, please call Rebecca Brown
(601-826-5200), Brittany Clayton (662-397-1159), Alissa Damiens (662-571-2911),
Natalie Keyes (601-966-3416), Gary Adam McPherson (601-938-1599), Anna
Elizabeth Wiygul (662-574-4774) or you may contact the chair of our research
committee, Carey McCarter, DNP, FNP-BC (662-295-1858). Your participation in this
study is strictly voluntary. The amount o f time required for us to review charts and
collect data will be approximately one month. In addition, you may withdraw your
consent and participation in this study at any time by contacting one o f us or the chair of
our research committee.
Sincerely,

Rebecca Brown, Brittany Clayton, Alissa Damiens, Natalie Keyes, Gary Adam
McPherson, and Anna Elizabeth Wiygul
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APPENDIX C
Opioid and Naloxone Prescribing Practices Data Collection Worksheet

Age:
Gender
Male
Female
Was non pharmacologic therapy initiated before nonopioid therapy?
a. No
______ b. Yes
Was nonopioid pharmacologic therapy initiated before opioid therapy?
a. No
______ b. Yes
Concurrent prescribing of opioids and benzodiazepines?
a. No
______ b. Yes
Urine drug screen prior to opioid initiation?
a. No
______ b. Yes
Was naloxone prescribed with the prescribed opioid?
______ a. No
______ b. Yes
Was education provided for overdose prevention and overdose awareness?
a. No
______ b. Yes
Pain related ICD 10__________
Provider’s Type
a. NP
b. MD
c. D.O.
d. PA

